Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy

American Journal of Respiratory and Critical Care Medicine
C L DaleyG F Schecter

Abstract

Between 1990 and 1994, we conducted a prospective study in five methadone maintenance clinics in San Francisco to determine the rate of tuberculosis (TB) in injection drug users, including those who were anergic. Of the 1,745 persons seen in the clinics, 1,109 completed an evaluation that included skin testing with tuberculin and at least two other antigens (mumps, tetanus, and/or Candida), as well as HIV testing. All persons with a positive tuberculin skin test (TST) and anergic individuals who had radiographic evidence of tuberculous infection (i.e., calcified granulomas) were offered isoniazid (INH) preventive therapy. The median follow-up was 22.0 mo. There were 338 (30.5%) human immunodeficiency virus (HIV)-seropositive patients and 771 (69.5%) HIV-seronegative patients; 96 (28.0%) and 336 (44.0%), respectively, had positive TSTs. Of the HIV-seropositive subjects, 108 (31.9%) had no reaction to any of the three antigens, and were therefore classified as anergic. The rate of TB among the HIV-seropositive, TST-positive patients who did not take INH preventive therapy was 5.0 per 100 person-yr, compared with 0.4 per 100 person-yr among the HIV-seronegative, TST-positive patients (p = 0.007). There were no cases of TB among th...Continue Reading

References

Dec 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R R MacGregorA L Graziani
Aug 1, 1993·Annals of Internal Medicine·S MorenoD López-Gay
Jun 1, 1996·American Journal of Respiratory and Critical Care Medicine·D P ChinP C Hopewell

❮ Previous
Next ❯

Citations

Dec 28, 1999·Journal of Urban Health : Bulletin of the New York Academy of Medicine·J LorvickJ K Watters
Dec 3, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert G DeissRichard S Garfein
Apr 9, 2005·Current Opinion in Pulmonary Medicine·Nicola PetrosilloPierluigi Viale
Apr 9, 2005·Current Opinion in Pulmonary Medicine·Keertan DhedaGraham A W Rook
Apr 17, 2007·Journal of Public Health Management and Practice : JPHMP·Jiehui LiUNKNOWN Tuberculosis Epidemiologic Studies Consortium
May 6, 2008·AIDS·María S SánchezWayne M Getz
Apr 13, 2011·Clinical Microbiology Reviews·Candice K Kwan, Joel D Ernst
Jul 3, 1999·American Journal of Respiratory and Critical Care Medicine·D C SnyderD P Chin
Aug 10, 2000·American Journal of Respiratory and Critical Care Medicine·A R MossP C Hopewell
Nov 19, 2013·PloS One·Sara C AuldWilliam R Mac Kenzie
May 16, 2000·Chest·M Lauzardo, D Ashkin
Oct 9, 2001·HIV Clinical Trials·N W Schluger, J Burzynski
Jun 28, 2007·Journal of Addictive Diseases·Shobha SwaminathanMarc N Gourevitch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

American Thoracic Association Journals

Discover the latest respiratory research published by the journals from the American Thoracic Society.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

© 2021 Meta ULC. All rights reserved